110 related articles for article (PubMed ID: 2949773)
1. Platelet acquired defect in PDGF and beta thromboglobulin content in hairy cell leukaemia: improvement after interferon therapy.
Dupuy E; Sigaux F; Bryckaert MC; Tobelem G; Castaigne S; Flandrin G; Degos L; Caen JP
Br J Haematol; 1987 Jan; 65(1):107-10. PubMed ID: 2949773
[TBL] [Abstract][Full Text] [Related]
2. Platelet-derived mitogenic activity and bone marrow fibrosis in myeloproliferative disorders.
Romano M; Viero P; Cortellazzo S; Barbui T; Donati MB; Poggi A
Haemostasis; 1990; 20(3):162-8. PubMed ID: 2143744
[TBL] [Abstract][Full Text] [Related]
3. Evidence that platelet density depends on the alpha-granule content in platelets.
van Oost BA; Timmermans AP; Sixma JJ
Blood; 1984 Feb; 63(2):482-5. PubMed ID: 6198014
[TBL] [Abstract][Full Text] [Related]
4. Platelet-derived growth factor release and antiplatelet treatment with low-dose acetylsalicylic acid.
Vissinger H; Husted SE; Kristensen SD; Nielsen HK
Angiology; 1993 Aug; 44(8):633-8. PubMed ID: 8342880
[TBL] [Abstract][Full Text] [Related]
5. Alpha interferon treatment of patients with hairy-cell leukaemia.
Hagberg H; Alm G; Björkholm M; Glimelius B; Killander A; Simonsson B; Sundström C; Ahre A
Scand J Haematol; 1985 Jul; 35(1):66-70. PubMed ID: 4048862
[TBL] [Abstract][Full Text] [Related]
6. Alpha-interferon in hairy cell leukaemia: direct effects on hairy cells or indirect cytotoxicity?
Sigaux F; Castaigne S; Lehn P; Dupuy E; Billard C; Gluckman JC; Boiron M; Falcoff E; Flandrin G; Degos L
Int J Cancer Suppl; 1987; 1():2-8. PubMed ID: 3476473
[TBL] [Abstract][Full Text] [Related]
7. Interferon-gamma in vivo reverses the increased platelet levels of platelet-derived growth factor and transforming growth factor-beta in patients with myelofibrosis with myeloid metaplasia.
Martyré MC; Magdelenat H; Calvo F
Br J Haematol; 1991 Mar; 77(3):431-5. PubMed ID: 1901495
[TBL] [Abstract][Full Text] [Related]
8. Increased intraplatelet levels of platelet-derived growth factor and transforming growth factor-beta in patients with myelofibrosis with myeloid metaplasia.
Martyré MC; Magdelenat H; Bryckaert MC; Laine-Bidron C; Calvo F
Br J Haematol; 1991 Jan; 77(1):80-6. PubMed ID: 1998600
[TBL] [Abstract][Full Text] [Related]
9. Platelet-derived growth factor (PDGF) in type 1 diabetes mellitus.
Guillausseau PJ; Dupuy E; Bryckaert MC; Timsit J; Chanson P; Tobelem G; Caen JP; Lubetzki J
Eur J Clin Invest; 1989 Apr; 19(2):172-5. PubMed ID: 2525095
[TBL] [Abstract][Full Text] [Related]
10. Growth factor release during preparation and storage of platelet concentrates.
Ledent E; Wasteson A; Berlin G
Vox Sang; 1995; 68(4):205-9. PubMed ID: 7660637
[TBL] [Abstract][Full Text] [Related]
11. Increased mitogenic activity of scleroderma serum: inhibitory effect of human recombinant interferon-gamma.
Bryckaert M; Fontenay M; Lioté F; Bellucci S; Carriou R; Tobelem G
Ann Rheum Dis; 1994 Nov; 53(11):776-9. PubMed ID: 7826142
[TBL] [Abstract][Full Text] [Related]
12. Peripheral and intrasplenic platelet kinetics and bone marrow megakaryopoiesis in alpha-2b-interferon treated hairy cell leukemia.
Wadenvik H; Braide I; Ridell B; Kutti J; Jacobsson S; Revesz P
Leuk Res; 1994 Aug; 18(8):569-75. PubMed ID: 8065159
[TBL] [Abstract][Full Text] [Related]
13. Alpha-2 interferon therapy of hairy-cell leukemia: a multicenter study of 64 patients.
Golomb HM; Jacobs A; Fefer A; Ozer H; Thompson J; Portlock C; Ratain M; Golde D; Vardiman J; Burke JS
J Clin Oncol; 1986 Jun; 4(6):900-5. PubMed ID: 3519880
[TBL] [Abstract][Full Text] [Related]
14. Human recombinant interferon-alpha-2 in the treatment of patients with hairy cell leukemia.
Skotnicki AB; Wolska-Smolen T; Blicharski J; Zduńczyk A; Sasiadek U; Pituch-Noworolska A
Cancer Detect Prev; 1988; 12(1-6):511-22. PubMed ID: 3180143
[TBL] [Abstract][Full Text] [Related]
15. Effect of alpha-interferon therapy on bone marrow fibrosis in hairy cell leukemia.
Laughlin M; Islam A; Barcos M; Meade P; Ozer H; Gavigan M; Henderson E; Han T
Blood; 1988 Sep; 72(3):936-9. PubMed ID: 3416078
[TBL] [Abstract][Full Text] [Related]
16. Treatment of hairy-cell leukaemia with alpha-interferon (alpha-IFN).
Lauria F; Foà R; Raspadori D; Zinzani PL; Buzzi M; Fierro MT; Bonferroni M; Fanin R; Gallizia C; Michieli MG
Eur J Cancer Clin Oncol; 1988 Feb; 24(2):195-200. PubMed ID: 3356206
[TBL] [Abstract][Full Text] [Related]
17. Recombinant alpha-2 interferon for treatment of hairy cell leukemia without prior splenectomy.
Ehmann WC; Silber R
Am J Med; 1986 Jun; 80(6):1111-4. PubMed ID: 3728508
[TBL] [Abstract][Full Text] [Related]
18. Megakaryocytes and myelofibrosis in gray platelet syndrome.
Caen JP; Deschamps JF; Bodevin E; Bryckaert MC; Dupuy E; Wasteson A
Nouv Rev Fr Hematol (1978); 1987; 29(2):109-14. PubMed ID: 3615193
[TBL] [Abstract][Full Text] [Related]
19. Hairy cell leukemia: an interferon deficient disease?
Hofmann V; Fehr J; Sauter C; Ottino J
Cancer Treat Rev; 1985 Dec; 12 Suppl B():33-7. PubMed ID: 3833328
[TBL] [Abstract][Full Text] [Related]
20. Rapid improvement in a terminal case of hairy cell leukemia treated with a new human recombinant interferon, IFN-alpha-C.
Aderka D; Levo Y; Rahmani R; Mory Y; Vaks B; Horowitz O; Doerner T; Shoham J; Wallach D; Revel M
Isr J Med Sci; 1985 Dec; 21(12):977-81. PubMed ID: 4093298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
